Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003)
Tabchy, A.B.Volume:
27
Year:
2016
Language:
english
Journal:
Breast Diseases: A Year Book Quarterly
DOI:
10.1016/j.breastdis.2016.04.014
File:
PDF, 62 KB
english, 2016